Healthcare News

September 25 2024 – Cancer and diabetes drugs expected to dominate 2025 Medicare negotiations under IRA

Cancer and diabetes drugs expected to dominate 2025 Medicare negotiations under IRA
BioAge Labs aims to raise $180M from IPO, private placement to fund obesity trials
Merck's Keytruda-LAG-3 combo fails to tame tough colorectal cancer in phase 3
Sanofi reportedly gets PE bids for consumer health unit
*please scroll down for all the latest news*

Check open job listings in your area

Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud
*please scroll down for all the latest news* image:

Cancer and diabetes drugs expected to dominate 2025 Medicare negotiations under IRA
BioAge Labs aims to raise $180M from IPO, private placement to fund obesity trials
Merck's Keytruda-LAG-3 combo fails to tame tough colorectal cancer in phase 3
Sanofi reportedly gets PE bids for consumer health unit
*please scroll down for all the latest news*

Check open job listings in your area

Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud
*please scroll down for all the latest news* image:

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

Leave a Comment

[mwai_chat window="true" fullscreen="true"]